Early CDT-Lung

Early CDT‑Lung is a venous blood test designed to detect autoantibodies that the immune system may produce in response to early lung‑cancer cells. The assay looks for a specific pattern of antibodies that have been associated with the presence of small, otherwise undetectable tumors. By providing this information, the test may support clinicians in deciding whether further imaging or surveillance is warranted for individuals at elevated risk, such as those with a significant smoking history or occupational exposures. Results are typically returned within the laboratory’s standard processing window. The price covers the blood draw, the autoantibody analysis, and a comprehensive report that includes a brief tele‑consultation to discuss the implications of the findings. This test is intended for adults seeking proactive lung‑cancer risk assessment before symptoms appear.